title: Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.
authors.forename: Catherine J
authors.initials: CJ
authors.lastname: Wu
authors.forename: Mark
authors.initials: M
authors.lastname: Gladwin
authors.forename: John
authors.initials: J
authors.lastname: Tisdale
authors.forename: Matthew
authors.initials: M
authors.lastname: Hsieh
authors.forename: Terence
authors.initials: T
authors.lastname: Law
authors.forename: Melinda
authors.initials: M
authors.lastname: Biernacki
authors.forename: Shelby
authors.initials: S
authors.lastname: Rogers
authors.forename: Xunde
authors.initials: X
authors.lastname: Wang
authors.forename: Mark
authors.initials: M
authors.lastname: Walters
authors.forename: David
authors.initials: D
authors.lastname: Zahrieh
authors.forename: Joseph H
authors.initials: JH
authors.lastname: Antin
authors.forename: Jerome
authors.initials: J
authors.lastname: Ritz
authors.forename: Lakshamanan
authors.initials: L
authors.lastname: Krishnamurti
mesh_terms: D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006461:Hemolysis / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018183:Transplantation Chimera; D019172:Transplantation Conditioning / Q000379:methods